NO970631L - Fremgangsmåter for behandling av sepsis eller betennelsessykdommer med oxypurin-nukleosider - Google Patents

Fremgangsmåter for behandling av sepsis eller betennelsessykdommer med oxypurin-nukleosider

Info

Publication number
NO970631L
NO970631L NO970631A NO970631A NO970631L NO 970631 L NO970631 L NO 970631L NO 970631 A NO970631 A NO 970631A NO 970631 A NO970631 A NO 970631A NO 970631 L NO970631 L NO 970631L
Authority
NO
Norway
Prior art keywords
methods
inflammatory diseases
oxypurine nucleosides
treating sepsis
treating
Prior art date
Application number
NO970631A
Other languages
English (en)
Norwegian (no)
Other versions
NO970631D0 (no
Inventor
Reid W Von Borstel
Michael K Bamat
Bradley M Hiltbrand
James C Butler
Shyam Shirali
Original Assignee
Pro Neuron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pro Neuron Inc filed Critical Pro Neuron Inc
Publication of NO970631D0 publication Critical patent/NO970631D0/no
Publication of NO970631L publication Critical patent/NO970631L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
NO970631A 1994-08-12 1997-02-11 Fremgangsmåter for behandling av sepsis eller betennelsessykdommer med oxypurin-nukleosider NO970631L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28921494A 1994-08-12 1994-08-12
PCT/US1995/010078 WO1996004923A1 (en) 1994-08-12 1995-08-08 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides

Publications (2)

Publication Number Publication Date
NO970631D0 NO970631D0 (no) 1997-02-11
NO970631L true NO970631L (no) 1997-04-11

Family

ID=23110539

Family Applications (3)

Application Number Title Priority Date Filing Date
NO970631A NO970631L (no) 1994-08-12 1997-02-11 Fremgangsmåter for behandling av sepsis eller betennelsessykdommer med oxypurin-nukleosider
NO20016068A NO317199B1 (no) 1994-08-12 2001-12-12 Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat for redusering av inflammasjon i et dyr
NO20041007A NO20041007L (no) 1994-08-12 2004-03-10 Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO20016068A NO317199B1 (no) 1994-08-12 2001-12-12 Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat for redusering av inflammasjon i et dyr
NO20041007A NO20041007L (no) 1994-08-12 2004-03-10 Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat

Country Status (12)

Country Link
US (1) US20040235782A1 (xx)
EP (2) EP1157698A3 (xx)
JP (2) JPH10507441A (xx)
KR (1) KR100290129B1 (xx)
AU (1) AU712835B2 (xx)
CA (1) CA2197205A1 (xx)
FI (1) FI970588A (xx)
IL (1) IL114887A0 (xx)
NO (3) NO970631L (xx)
RU (1) RU2203669C2 (xx)
WO (1) WO1996004923A1 (xx)
ZA (1) ZA956679B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19818044A1 (de) * 1998-04-22 1999-10-28 Klinge Co Chem Pharm Fab Verwendung von Vitamin-PP-Verbindungen
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
WO2001081346A2 (en) 2000-04-25 2001-11-01 Icos Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
CA2452909A1 (en) * 2001-12-07 2003-06-13 Intercell Ag Immunostimulatory oligodeoxynucleotides
EP1549652B1 (en) 2002-09-30 2008-10-22 Bayer HealthCare AG Fused azole-pyrimidine derivatives
US6997018B2 (en) 2003-06-02 2006-02-14 Ferro Corporation Method of micro and nano texturing glass
US7932260B2 (en) 2004-05-13 2011-04-26 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
US9186406B2 (en) 2007-08-16 2015-11-17 The Henry M. Jackson Foundation for Advancement of Military Medicine, Inc. Compositions containing nucleosides and manganese and their uses
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
CA2975473C (en) 2008-11-13 2021-01-19 Gilead Calistoga Llc Therapies for hematologic malignancies
JP2012521994A (ja) 2009-03-24 2012-09-20 ギリアード カリストガ エルエルシー ２−プリニル−３−トリル−キナゾリノン誘導体のアトロプ異性体および使用方法
ES2548253T3 (es) 2009-04-20 2015-10-15 Gilead Calistoga Llc Métodos para el tratamiento de tumores sólidos
CA2768843A1 (en) 2009-07-21 2011-01-27 Gilead Calistoga Llc Treatment of liver disorders with pi3k inhibitors
US9234168B2 (en) * 2010-04-29 2016-01-12 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Compositions containing amino acids, phosphate and manganese and their uses
WO2013134288A1 (en) 2012-03-05 2013-09-12 Gilead Calistoga Llc Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
AU2014364414A1 (en) 2013-12-20 2016-06-30 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S) -2-(1-(9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3H) -one
JP2017502021A (ja) 2013-12-20 2017-01-19 ギリアード カリストガ エルエルシー ホスファチジルイノシトール３−キナーゼ阻害剤のためのプロセス方法
EP3154960A1 (en) 2014-06-13 2017-04-19 Gilead Sciences, Inc. Phosphatidylinositol 3-kinase inhibitors
BR112023003444A2 (pt) * 2020-08-24 2023-05-02 Adama Makhteshim Ltd Compostos e composições pesticidas, métodos de uso e processos de preparação dos mesmos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2158269C2 (ru) * 1991-02-08 2000-10-27 Про-Ньюрон, Инк. Ацильные производные гуанозина, инозина, ксантозина, дезоксиинозина, дезоксигуанозина, инозин-2',3'-(ациклического)диалкоголя или их фармацевтически приемлемые соли, фармацевтическая композиция, стимулирующая гемопоэз, способ лечения цитопении
US5320846A (en) * 1991-04-17 1994-06-14 New England Deaconess Hospital Corp. Method and composition for testing patients with metabolic depleting diseases

Also Published As

Publication number Publication date
JPH10507441A (ja) 1998-07-21
NO20016068D0 (no) 2001-12-12
CA2197205A1 (en) 1996-02-22
NO20041007L (no) 2004-03-10
FI970588A0 (fi) 1997-02-12
AU3278495A (en) 1996-03-07
NO20016068L (no) 1997-04-11
EP0771204A1 (en) 1997-05-07
KR100290129B1 (ko) 2001-05-15
AU712835B2 (en) 1999-11-18
EP1157698A2 (en) 2001-11-28
ZA956679B (en) 1997-02-10
NO970631D0 (no) 1997-02-11
EP0771204A4 (en) 1999-10-20
NO317199B1 (no) 2004-09-13
WO1996004923A1 (en) 1996-02-22
JP2009221221A (ja) 2009-10-01
RU2203669C2 (ru) 2003-05-10
FI970588A (fi) 1997-04-11
US20040235782A1 (en) 2004-11-25
IL114887A0 (en) 1995-12-08
EP1157698A3 (en) 2002-05-02
KR970704457A (ko) 1997-09-06

Similar Documents

Publication Publication Date Title
NO970631L (no) Fremgangsmåter for behandling av sepsis eller betennelsessykdommer med oxypurin-nukleosider
NO180538C (no) N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer, farmasöytiske blandinger som inneholder dem og mellomprodukter ved fremstilling av derivatene
TR199800825T2 (xx) Farnesil protein transferini inhibe eden (imidazol-5-il) metil-2-kinolinon t�revleri.
LV12209A (lv) Ar fenilgrupu aizvietoti heterocikli ka ciklooksigenazes-2 inhibitori
TR199801168T2 (xx) �nterleukin-1 beta d�n��t�r�c� enzim inhibit�rleri.
EA200100623A1 (ru) Кетолидные антибиотики
NO20006323D0 (no) Glykopeptidderivater og farmasöytiske sammensetninger som inneholder disse
NL980012I2 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
NO20061455L (no) 2,6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
EA200100416A1 (ru) 13-членные азалиды и их применение в качестве антибиотических агентов
ATE154347T1 (de) Benzisothiazolinon-1-dioxyde als elastase- inhibitoren
ATE179615T1 (de) Oxypurin-nukleoside und seine artverwandten, und acylderivate davon, zur verbesserung der hämatopoese
AU6319480A (en) 2-hydroxyalkyl-3,4,5-trihydroxypiperidines
DK164191C (da) Fungicid og fremgangsmaader til dets fremstilling og til dets anvendelse til bekaempelse af svampe
DE69613395T2 (de) Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel
EA199800534A1 (ru) ПРИМЕНЕНИЕ 2-ЭТИЛГЕКСИЛ-α-ЦИАНО-β, β-ДИФЕНИЛАКРИАТА ДЛЯ УЛУЧШЕНИЯ СТАБИЛЬНОСТИ КОСМЕТИЧЕСКИХ КОМПОЗИЦИЙ, СОДЕРЖАЩИХ П-МЕТИЛБЕНЗИЛИДЕНКАМФОРУВ СОЧЕТАНИИ С ДИБЕНЗОИЛМЕТАНОВЫМ ПРОИЗВОДНЫМ
NO983511D0 (no) Difenylstilbener som pro-legemidler for COX-2-inhibitorer
NO943765L (no) Aryloksybenzen-herbicidmidler
EA200200292A1 (ru) Производные гигромицина
ES2166834T3 (es) Uso de agentes antiviricos de aminopurina para el tratamiento y profilaxis de infecciones latentes de herpesvirus.
EA199800368A1 (ru) Новые промежуточные продукты и их использование для получения n,n'-мостиковых бисиндолилмалеимидов
TR200003249T2 (tr) 2''-Deoksi higromisin türevleri
ATE7901T1 (de) Neue antibiotisch wirksame verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application